CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
EnglishCAPPELLINI, ALESSANDRA
Dipartimento:
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Ruolo:
Ricercatori
Risultati 1 - 20 di 48 (tempo di esecuzione: 0.001 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | |
|---|---|---|---|---|---|---|
| 1 | Widespread impairment of cell proliferation in the neonate Ts65Dn mouse, a model for Down syndrome. | Contestabile A; Fila T; Cappellini A; Bartesaghi R; Ciani E | 2009 | CELL PROLIFERATION | 1.01 Articolo in rivista | |
| 2 | Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. | A.M. Martelli; F. Chiarini; C. Evangelisti; A. Cappellini; F. Buontempo; D. Bressanin; M. Fini; J.A. McCubrey | 2012 | ONCOTARGET | 1.01 Articolo in rivista | |
| 3 | Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. | A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli. | 2014 | CELL CYCLE | 1.01 Articolo in rivista | |
| 4 | Therapeutic targeting of CK2 in acute and chronic leukemias. | Buontempo, F.; Orsini, E.; Ruzzene, M.; Mccubrey, J. A.; Chiarini, F.; Cappellini, A.; Lonetti, A.; Evangelisti, C.; Evangelisti, C.; Barata, J. T.; Martelli, ALBERTO MARIA | 2018 | LEUKEMIA | 1.01 Articolo in rivista | |
| 5 | Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia | Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontempo; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli. | 2014 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1.01 Articolo in rivista | |
| 6 | The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resisten human T-acute leukemia cells by a JNK-dependent mechanism | Chiarini F.; Del Sole M.; Mongiorgi S.; Gaboardi G.C.; Cappellini A.; Mantovani I.; Follo M.Y.; McCubrey J.A.; Martelli A.M. | 2008 | LEUKEMIA | 1.01 Articolo in rivista | |
| 7 | The emerging role of the phosphatidylinositol 3-kinase/Akt/mTOR signaling network in normal myelopoieis and leukemogenesis. | A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Cappellini; A. Ognibene; J.A. McCubrey. | 2010 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1.01 Articolo in rivista | |
| 8 | The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage | A. Cappellini; F. Chiarini; A. Ognibene; J.A. McCubrey; A.M. Martelli | 2009 | CELL CYCLE | 1.01 Articolo in rivista | |
| 9 | The Akt/mammalian target of rapamycin signal transduction pathway is activated in high-risk myelodysplastic syndromes and influences cell survival and proliferation | Follo, Matilde Y.; Mongiorgi, Sara; Bosi, Costanza; Cappellini, Alessandra; Finelli, Carlo; Chiarini, Francesca; Papa, Veronica; Libra, Massimo; Martinelli, Giovanni; Cocco, Lucio; Martelli, Alberto M. | 2007 | CANCER RESEARCH | 1.01 Articolo in rivista | |
| 10 | Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies | Alberto M Martelli;Francesca Chiarini;Camilla Evangelisti;Andrea Ognibene;Daniela Bressanin;Anna Maria Billi;Lucia Manzoli;Alessandra Cappellini;James A McCubrey | 2012 | EXPERT OPINION ON THERAPEUTIC TARGETS | 1.01 Articolo in rivista | |
| 11 | Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. | A.M. Martelli; A. Lonetti; F. Buontempo; F. Ricci; P.L. Tazzari; C. Evangelisti; D. Bressanin; A. Cappellini; E. Orsini; F. Chiarini. | 2014 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | |
| 12 | Synergistic induction of apoptosis in human leukemia T cells by the Akt inhibitor perifosine and etoposide through activation of intrinsic and Fas-mediated extrinsic cell death pathways | Nyakern M.; Cappellini A.; Mantovani I.; Martelli A.M. | 2006 | MOLECULAR CANCER THERAPEUTICS | 1.01 Articolo in rivista | |
| 13 | Synergistic cytotoxic effects of bortezomib and CK2 inhibitor CX-4945 in acute lymphoblastic leukemia: turning off the prosurvival er chaperone BIP/GRP78 and turning on the pro-apoptotic NF-κB. | Buontempo, F; Orsini, E; Lonetti, A; Cappellini, A; Chiarini, F; Evangelisti, C; Evangelisti, C; Melchionda, F; Pession, A; Bertaina, A; Locatelli, F; Bertacchini, J; Neri, Lm; Mccubrey, Ja; Martelli, Am. | 2016 | ONCOTARGET | 1.01 Articolo in rivista | |
| 14 | Specific presence of PKC isoforms in low and fast proliferation Moris hepatoma cells | P. Santi; L. Solimando; A.M. Billi; A. Cappellini; M.Y. Follo; N. Zini; L. Guidotti | 2004 | ITALIAN JOURNAL OF ANATOMY AND EMBRYOLOGY | 4.02 Riassunto (Abstract) | |
| 15 | SELECTIVE EFFECT OF LENALIDOMIDE ON CELL CYCLE AND INOSITIDE-DEPENDENT ERYTHROID SIGNALLING IN DEL(5Q) CELLS AND MYELODYSPLASTIC SYNDROMES (MDS) | Follo, My; Mongiorgi, S; Clissa, C; Poli, A; Lonetti, A; Stanzani, M; Cappellini, A; Billi, Am; Manzoli, L; Cocco, L; Finelli, C | 2014 | 4.02 Riassunto (Abstract) | ||
| 16 | Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? | Salaroli R.; Di Tomaso T.; Ronchi A.; Ceccarelli C.; Cammelli S.; Cappellini A.; Martinelli GN.; Barbieri E.; Giangaspero F.; Cenacchi G. | 2008 | JOURNAL OF NEURO-ONCOLOGY | 1.01 Articolo in rivista | |
| 17 | Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells | V. Papa; P.L. Tazzari; F. Chiarini; A. Cappellini; F. Ricci; A.M. Billi; C. Evangelisti; E. Ottaviani; G. Martinelli; N. Testoni; J.A. McCubrey; A.M. Martelli | 2008 | LEUKEMIA | 1.01 Articolo in rivista | |
| 18 | Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. | Falà F; Blalock WL; Tazzari PL; Cappellini A; Chiarini F; Martinelli G; Tafuri A; McCubrey JA; Cocco L; Martelli AM | 2008 | MOLECULAR PHARMACOLOGY | 1.01 Articolo in rivista | |
| 19 | PKC inhibitors induced apoptosis in Morris hepatoma | M.Y. Follo; A. Cappellini; L. Solimando; L. Guidotti; P. Santi | 2005 | EUROPEAN JOURNAL OF HISTOCHEMISTRY | 4.02 Riassunto (Abstract) | |
| 20 | PI3K pan-inhibition impairs more efficiently proliferation and survival of T-cell acute lymphoblastic leukemia cell lines when compared to isoform-selective PI3K inhibitors. | Lonetti, A.; Cappellini, A.; Spartà, A.M.; Chiarini, F.; Buontempo, F.; Evangelisti, C.; Evangelisti, C.; Orsini, E.; Mccubrey, J.A.; Martelli, A.M. . | 2015 | ONCOTARGET | 1.01 Articolo in rivista |
Nome completo:
CAPPELLINI, ALESSANDRA
Copyright © 2019